O'Shaughnessy Asset Management, LLC Intellia Therapeutics, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$38.49 - $76.21 $122,398 - $242,347	-3,180 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$58.27 - $118.99 $27,678 - $56,520	-475 Reduced 13.0%	3,180 $231,000
Q4 2021 Feb 11, 2022	SELL	$100.76 - $138.36 $302 - $415	-3 Reduced 0.08%	3,655 $432,000
Q3 2021 Nov 10, 2021	BUY	$132.37 - $176.78 $111,323 - $148,671	841 Added 29.85%	3,658 $492,000
Q2 2021 Aug 09, 2021	SELL	$60.88 - $161.91 $7,975 - $21,210	-131 Reduced 4.44%	2,817 $456,000
Q1 2021 May 14, 2021	SELL	$46.59 - $83.68 $2,748 - $4,937	-59 Reduced 1.96%	2,948 $236,000
Q4 2020 Feb 11, 2021	BUY	$18.83 - $63.53 $56,621 - $191,034	3,007 New	3,007 $164,000

313

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.09B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.